Kanoria Chemicals & Industries Ltd · NSE:KANORICHEM

Kanoria Chemicals & Industries — Shareholder Meeting (September 2025)

13 slides from Kanoria Chemicals & Industries's shareholder meeting presentation, Sep 26, 2025

  1. Slide 1: Filing cover letter: AGM Presentation

    BKANORIA CHEMICALS INDUSTRIES UMITED & Registered Office: KCI Plaza. 6th Floor 23C. Ashutosh Chowdhury Avenue Kolkata-700 019 Tel: +9 1- 3 3 -4 0 3 I - 3 2 0 0 CIN :L2411 OWB1960PLC02491 0 E-mail:calall@kanoriachem.com Website: www.kanoriachem.com KC-13/ Date: 26.09.2025 To, To, The Manager, The Sec

  2. Slide 2: 65th Annual General Meeting

    65th Annual General Meeting September 26, 2025

  3. Slide 3: Disclaimer

    Disclaimer Except for historical information and discussions contained herein, statements included in this presentation may constitute “forward looking statements”. These statements involve a number of risks, uncertainties and other factors that could cause actual results to differ from those that m

  4. Slide 4: Key Highlights FY'2024-25

    KEY HIGHLIGHTS FY’ 2024-25 3

  5. Slide 5: Standalone results: improved efficiencies and realisations

    (INR in lakhs)  Improved efficiencies and realisations FY'2025 FY'2024 Operating Revenue 67,830 57,686  Operating Revenue increased by 18% Other Income 1,425 2,524  EBITDA increased by 69% EBITDA 5,358 3,169 Finance Cost 1,607 1,154  Exceptional Item represents non cash EBTDA 3,751 2,016 impairm

  6. Slide 6: Subsidiary results: almost flat revenue, negative EBITDA

    (INR in lakhs)  Almost flat revenue FY'2025 FY'2024  Negative EBITDA – decreased realisation; higher Operating Revenue 78,240 79,007 development cost allocation due to rapid Other Income 185 81 technological changes EBITDA (663) 2,771 Finance Cost 1,688 1,451 EBTDA (2,351) 1,320 Depreciation 3,069

  7. Slide 7: Ethiopia results affected by Birr devaluation

     Results are not comparable as a result of sharp (INR in lakhs) devaluation of Ethiopian Birr by almost 130% FY'2025 FY'2024 post foreign currency liberalization measures Operating Revenue 7,601 10,811 announced in July’24 by Government of Ethiopia Other Income 797 109 EBITDA 128 1,850  The revenu

  8. Slide 8: Consolidated Profitability

    Consolidated Profitability (INR in lakhs) FY'2025 FY'2024 Operating Revenue 1,53,672 1,47,505 Other Income 921 1,925 EBITDA 4,058 7,154 Finance Cost 4,579 4,302 Exceptional Item represents EBTDA (521) 2,852 impairment of Goodwill created Depreciation 6,260 5,932 at the time of acquisition of EBT & E

  9. Slide 9: Future Outlook

    FUTURE OUTLOOK 8

  10. Slide 10: Favourable business prospects and planned initiatives

     Favourable business prospects with growing demand from Company’s customers segment  Launch of new product ‘Triacetene’ by the end of this fiscal.  Undertaking Phenol Formaldehyde Resin expansion at its Ankleshwar unit  Programs for development of Penta derivative and reduction of steam cost in

  11. Slide 11: APAG strategic investor: Anand Group acquires 63% equity

     With challenges of technology disruption: cheaper Asian alternatives and higher allocation of development cost, APAG decided to rope in a Strategic Investor.  India’s “Anand Group” decided to join hands and have acquired 63% of APAG’s equity for EUR 17.78 mn.  KCI’s participation in APAG diluted

  12. Slide 12: Ethiopia liberalisation measures and expected improvement

     Ethiopia announced a slew of liberalisation measures relating to foreign currency, capital markets, foreign bank collaboration etc., which were all aimed at over all growth of the country  These liberalisations are ensuring better availability of foreign exchange and making the Company’s products

  13. Slide 13: Thank You

    TIH AIN K; |Y\O\|U E KCL =

Kanoria Chemicals & Industries — Shareholder Meeting (September 2025) on 6ix